News + Filings Transactions
|
STARR KEVIN P
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/15/2023 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $56.10 | $561k | | 06/15/2023 |
| 06/16/2022 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 9.9k | $31.36 | $311.9k | | 06/16/2022 |
| 06/16/2021 | Sage Therapeutics, Inc. | SAGE | Purchase | Common Stock | 17.8k | $56.05 | $1000k | | 06/16/2021 |
| 06/10/2021 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $76.09 | $760.9k | | 06/10/2021 |
| 06/09/2020 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $36.47 | $364.7k | | 06/09/2020 |
| 06/05/2019 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $177.41 | $1.8M | | 06/05/2019 |
| 06/06/2018 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $154.06 | $1.5M | | 06/06/2018 |
| 04/18/2018 | Sage Therapeutics, Inc. | SAGE | Sale | Common Stock | 24k | $168.28 | $4M | | 04/17/2018 |
| 04/17/2018 | Sage Therapeutics, Inc. | SAGE | Sale | Common Stock | 35k | $169.25 | $5.9M | | 04/17/2018 |
| 03/07/2018 | MyoKardia, Inc. | MYOK | Other (disposition) | Common Stock | 2M | $0.00 | $0 | See Footnote | 03/07/2018 |
| 02/16/2018 | Sage Therapeutics, Inc. | SAGE | Other (disposition) | Common Stock | 510.6k | $0.00 | $0 | See Footnote | 02/16/2018 |
| 01/03/2018 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 816.3k | $42.00 | $34.3M | See footnote | 01/03/2018 |
| 12/06/2017 | MyoKardia, Inc. | MYOK | Other (disposition) | Common Stock | 2M | $0.00 | $0 | See Footnote | 12/06/2017 |
| 09/28/2017 | MyoKardia, Inc. | MYOK | Other (disposition) | Common Stock | 2M | $0.00 | $0 | See Footnote | 09/28/2017 |
| 09/27/2017 | Sage Therapeutics, Inc. | SAGE | Other (disposition) | Common Stock | 545k | $0.00 | $0 | See Footnote | 09/27/2017 |
| 09/26/2017 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 400k | $43.00 | $17.2M | See Footnote | 09/25/2017 |
| 09/25/2017 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 201.4k | $43.00 | $8.7M | See Footnote | 09/25/2017 |
| 09/08/2017 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 200.4k | $41.00 | $8.2M | See Footnote | 09/08/2017 |
| 09/08/2017 | MyoKardia, Inc. | MYOK | Sale | Common Stock | 900 | $42.39 | $38.1k | See Footnote | 09/08/2017 |
| 07/18/2017 | Sage Therapeutics, Inc. | SAGE | Other (disposition) | Common Stock | 800k | $0.00 | $0 | See Footnote | 07/18/2017 |
| 06/14/2017 | MyoKardia, Inc. | MYOK | Grant | Stock Option (Right to Buy) | 11k | $14.00 | $154k | | 06/14/2017 |
| 06/07/2017 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 14k | $72.74 | $1M | | 06/07/2017 |
| 06/02/2017 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 11.2k | $71.99 | $809.9k | | 06/02/2017 |
| 04/12/2017 | CytomX Therapeutics, Inc. | CTMX | Sale | Common Stock | 28.4k | $16.36 | $463.8k | | 04/12/2017 |
| 03/30/2017 | MyoKardia, Inc. | MYOK | Other (disposition) | Common Stock | 850k | $0.00 | $0 | See Footnote | 03/30/2017 |
| 01/23/2017 | Sage Therapeutics, Inc. | SAGE | Other (disposition) | Common Stock | 1000k | $0.00 | $0 | See Footnote | 01/23/2017 |
| 12/19/2016 | Blueprint Medicines Corp | BPMC | Sale | Common Stock | 106.5k | $28.19 | $3M | | 12/19/2016 |
| 12/16/2016 | Global Blood Therapeutics, Inc. | GBT | Sale | Common Stock | 109k | $16.00 | $1.7M | | 12/16/2016 |
| 11/29/2016 | MyoKardia, Inc. | MYOK | Other (disposition) | Common Stock | 850k | $0.00 | $0 | See Footnote | 11/29/2016 |
| 09/06/2016 | Editas Medicine, Inc. | EDIT | Sale | Common Stock | 5.9k | $15.90 | $93.7k | | 09/06/2016 |
| 08/19/2016 | Sage Therapeutics, Inc. | SAGE | Other (disposition) | Common Stock | 1000k | $0.00 | $0 | See Footnote | 08/19/2016 |
| 06/22/2016 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Options (Right to buy) | 13.9k | $28.35 | $394.7k | | 06/22/2016 |
| 06/07/2016 | MyoKardia, Inc. | MYOK | Grant | Stock Option (Right to Buy) | 11k | $13.60 | $149.6k | | 06/07/2016 |
| 06/03/2016 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 11.2k | $70.20 | $789.8k | | 06/03/2016 |
| 05/16/2016 | Sage Therapeutics, Inc. | SAGE | Sale | Common Stock | 850k | $31.25 | $26.6M | See Footnote | 05/16/2016 |
|
|